1-3 of 3
Kenichi Aoki
Close
Sort by
Journal Articles

Predictive Significance of Serum Beta 2-Microglobulin Levels and M-Protein Velocity for Symptomatic Progression of Smoldering Multiple Myeloma

Tsuyoshi Muta, MDPhD, Shinsuke Iida, MD PhD, Kosei Matsue, MD PhD, Kazutaka Sunami, Jun Isoda, MD PhD, Naoko Harada, MD PhD, Yoshio Saburi, MD PhD, Seiichi Okamura, MD PhD, Kyouya Kumagae, MD PhD, Junichi Watanabe, MD PhD, Junya Kuroda, MD PhD, Kenichi Aoki, MD, Ryosuke Ogawa, MD PhD, Toshihiro Miyamoto, MD PhD, Koichi Akashi, MD PhD, Yasushi Takamatsu, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3379.
https://doi.org/10.1182/blood.V124.21.3379.3379
Published: 2014
Journal Articles

Individually Tailored Treatment Strategies For Frail Myeloma Patients In Japan

Ryosuke Ogawa, MD, PhD, Takanori Ohta, MD, Kenichi Aoki, MD, Hirotake Kusumoto, MD, Mariko Minami, MD, Masakazu Higuchi, MD, PhD, Yasuhiro Sugio, MD, Yuju Ohno, MD
Journal: Blood
Blood (2013) 122 (21): 5614.
https://doi.org/10.1182/blood.V122.21.5614.5614
Published: 2013
Journal Articles

Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice

Kazuya Shimoda, Hiroko Tsutsui, Kenichi Aoki, Kouji Kato, Tadashi Matsuda, Akihiko Numata, Ken Takase, Tetsuya Yamamoto, Hideyuki Nukina, Tomoaki Hoshino, Yoshinobu Asano, Hisashi Gondo, Takashi Okamura, Seiichi Okamura, Kei-Ichi Nakayama, Kenji Nakanishi, Yoshiyuki Niho, Mine Harada
Journal: Blood
Blood (2002) 99 (6): 2094–2099.
https://doi.org/10.1182/blood.V99.6.2094
Published: 2002